Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure
In: Frontiers in Cardiovascular Medicine, Jg. 11 (2024-05-01)
Online
academicJournal
Zugriff:
BackgroundAcute coronary syndrome (ACS) remains a risk factor for heart failure (HF). Therefore, we aimed to assess the cardioprotective role of sodium–glucose cotransporter-2 (SGLT2) inhibitors post-ACS in patients with acute HF (AHF) and diabetes.MethodsWe conducted a retrospective observational cohort study employing propensity score matching. This study involved patients with diabetes admitted with ACS complicated by AHF, defined as either new clinical HF requiring diuretics during the index admission or having an ejection fraction (EF) of
| Titel: |
Sodium–glucose cotransporter-2 inhibitors improve cardiovascular outcomes post-acute coronary syndrome complicated by acute heart failure
|
|---|---|
| Autor/in / Beteiligte Person: | Rahhal, Alaa ; Hamamyh, Tahseen ; Chapra, Ammar ; Zaza, Khaled J. ; Najim, Mostafa ; Hemadneh, Mohammad ; Faraj, Hazem ; Kanjo, Wael ; Yasin, Ahmed ; Toba, Haneen ; Mohammed, Wafa ; Mohammad Khair Hamad ; Al-Tikrety, Nawras ; Mhd Baraa Habib ; Awaisu, Ahmed ; Mahfouz, Ahmed ; Alyafei, Sumaya ; Abdul Rahman Arabi ; Patel, Ashfaq ; Al-Hijji, Mohammed |
| Link: | |
| Zeitschrift: | Frontiers in Cardiovascular Medicine, Jg. 11 (2024-05-01) |
| Veröffentlichung: | Frontiers Media S.A., 2024 |
| Medientyp: | academicJournal |
| ISSN: | 2297-055X (print) |
| DOI: | 10.3389/fcvm.2024.1383669 |
| Schlagwort: |
|
| Sonstiges: |
|